Tag: Patients
Search News
Personalised ovarian cancer risk prediction reduces worries
18th May 2020
Offering personalised ovarian cancer risk prediction to women shows that 98 per cent of participants felt less worried after finding out their ovarian cancer risk status, according to a new study.
Read more
Metal analysis of urine for pancreatic cancer detection
28th April 2020
Research has revealed that the signature of metal ions present in urine samples is an accurate indicator of pancreatic ductal adenocarcinoma, one of the deadliest types of cancer.
Read more
New and valuable insights into familial myeloid leukaemia
3rd March 2020
Research has identified new genetic features implicated in a type of blood cancer known as familial myeloid leukaemia. The study, published in Nature Communications, offers novel insights into the biology of this inherited cancer, and provides a framework to inform how to more effectively manage at-risk individuals and patients affected by this type of blood malignancy.
Read more
Immune therapy reduces risk of recurrence in aggressive breast cancer
27th February 2020
An immune therapy for the most aggressive form of breast cancer can substantially reduce the risk of the disease returning, according to a clinical trial led by Professor Peter Schmid of Barts Cancer Institute, Queen Mary University of London.
Read more
World Cancer Day 2020
4th February 2020
This World Cancer Day, hear from our Director and some of our researchers about the importance of international collaboration in the fight against cancer.
Read more
IBIS-II – new results from international breast cancer study
12th December 2019
The Queen Mary University of London professor leading an international breast cancer study says anastrozole – rather than tamoxifen – should be the preventive drug-of-choice for post-menopausal women at increased risk of developing the disease.
Read more